MGI Launches Ultra High Speed DNBSEQ-G99 Gene Sequencer* with Mid to Low Range Throughput
SHENZHEN, China, Sept. 19, 2022 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI) on 9 September officially launched DNBSEQ-G99*, the latest model of the gene sequencer* with mid to low range throughput. As one of the sequencers* with the fastest speed among those with the same throughput in the world, DNBSEQ-G99* is especially suitable for targeted gene sequencing and...
Hummingbird Bioscience Chief Scientific Officer Jerome Boyd-Kirkup to Present at the 2nd Annual VISTA Virtual Symposium
SINGAPORE, Sept. 19, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced that Jerome Boyd-Kirkup, Ph.D., Hummingbird Bioscience's Chief Scientific Officer, will present at the 2nd Annual VISTA Symposium on September 23, 2022. "VISTA is a promising therapeutic target we believe has not been adequately drugged to...
HistoSonics Announces Published Results of Phase I Liver Tumor Trial
As Company Advances Planning for FDA Submission and Future Growth MINNEAPOLIS, Sept. 19, 2022 /PRNewswire/ -- HistoSonics, (www.histosonics.com), the developer and manufacturer of a completely non-invasive platform and proprietary sonic beam therapy, announced today the publication of results from their prospective Phase I clinical trial, named the THERESA Trial, conducted in...
Anyong Biotechnology’s Locally Sourced ‘Santé Silver Perch Essence’ Fulfilling Increasing Demand in The APAC Wellness Industry
KAOHSIUNG, Taiwan, Sept. 19, 2022 /PRNewswire/ -- Taiwan-based Anyong Biotechnology, has created a locally-sourced Santé Silver Perch Essence out of ecologically farmed, certified, and traceable silver perch in major markets such as Taiwan, the United States, Singapore, and Malaysia. As consumers' demands have for the product in the health and wellness industry are increasing, Anyong Biotechnology has developed a...
Taiwan’s Anyong Biotechnology First To Employ Seafood Stem-Cell Freezing
KAOHSIUNG, Taiwan, Sept. 19, 2022 /PRNewswire/ -- Anyong Biotechnology, the world-class aquatic food processing company based in Taiwan, is now the first company in the region to employ Cells Alive System (CAS) technology from Japan. It ranks as the most advanced freezing technology in Asia and is among the top three worldwide. Originally a medical-grade technology for freezing...
Dietary Leader EinFit Builds a Healthy Lifestyle with Award-Winning Supplements
Good habits and effective supplements to help you live the best life TAICHUNG, Taiwan, Sept. 19, 2022 /PRNewswire/ -- EinFit, the dietary supplement foods manufacturer based in Taiwan, is leading the way to embrace a healthier lifestyle with its additive-free health supplement products and advocacy for good health practices. Healthy lifestyle for a better quality life EinFit founder Franky...
MagicTouch SCB receives IDE approval for In-Stent Restenosis indication
TAMPA, Fla., Sept. 19, 2022 /PRNewswire/ -- The US FDA has granted an Investigational Device Exemption (IDE) approval for MagicTouch Sirolimus Coated Balloon (SCB) indicated for In-Stent Restenosis (ISR). World's first IDE approved Sirolimus Coated Balloon in Coronary - MagicTouch SCB US FDA's IDE approval allows the MagicTouch SCB to be...
Who is Hussain: World Record Smashed as British Charity Recruits over 37,000 Blood Donors On Single Day
World record broken for the most blood donations in one calendar day, across 27 countries in over 350 venues worldwide. 37,018 blood donations made in this record-breaking campaign could save over 110,000 lives. The Global Blood Heroes campaign was coordinated by the social justice organisation Who is Hussain in partnership with local and national blood donor organisations, including the...
Antengene Announces ATG-101 Granted Orphan Drug Designation by the U.S. FDA
SHANGHAI and BUCKS COUNTY, Pa., Sept. 20, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematology and oncology, today announced that ATG-101, the company's in-house developed novel PD-L1/4-1BB bispecific antibody, has been granted an...
Everest Medicines Appoints Rogers Yongqing Luo as Chief Executive Officer to Lead Next Stage of Company Growth
SHANGHAI, Sept. 19, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets, announced that it has appointed Rogers Yongqing Luo as Chief Executive Officer of the Company, effective immediately. Mr. Luo will also serve as an Executive...
